MAR PLUS

MAR PLUS is owned by STADA Arzneimittel AG (controlled by Bain Capital and Cinven), headquartered in Germany. No. The ultimate owner of MAR PLUS, STADA Arzneimittel AG (controlled by Bain Capital and Cinven), is headquartered in Germany, not in the United States.

STADA is a leading international pharmaceutical company focused on a three-pillar strategy consisting of generics, specialty pharma, and consumer healthcare products.